Menu

Top Stories

Published on Thursday, April 11, 2019

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

On April 3, 2019, Francis Collins, MD, PhD, director of the National Institutes of Health (NIH), Mikael Dolsten, MD, PhD, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer, joined in a discussion led by Susan Dentzer, visiting fellow at the Robert J. Margolis Center for Health Policy, Duke University, in Washington DC.

Photo: Francis Collins, MD, PhD, director of the NIH (left) and author Alejandro Hernandez, editorial manager of the Alpha-1 Foundation (right)

For 60 minutes, Collins, Dolsten, and Dentzer engaged in a conversation with the theme of: “Advancing the innovation ecosystem: working together for patients,” where they emphasized the need for continued collaboration between the private and public sectors, along with the patient community, in order to advance new and emerging technologies and innovative approaches for potentially life-saving treatments and new outcomes in medicine.

“We are currently living in remarkable times with amazing things happening in areas such as cancer immuno-therapy, gene therapy, and gene editing. The things that are happening right now, I had no idea they would even be possible just five or six years ago,” expressed Collins when asked about the current position “the ecosystem,” as they described the collaboration between the private and public sectors with small biotech companies; an ecosystem with symbiotic characteristics where all contributors play an important role in a tremendous team effort, in medical research.

Collins and Dolsten agreed on the importance of advocacy groups and organizations as well as the patient community, in being part of the process for better outcomes and the ability to bring new and potential treatments for various conditions to the clinic, including rare diseases, such as Alpha-1 Antitrypsin Deficiency (Alpha-1). 

“We need you, the patient community, you are the reason we have gotten this far,” said Collins.

“One of the most important resources needed for this ecosystem to strive is you, the patient. We need to line-up our resources and keep the ecosystem going, including the patient community. There is no one better to bring together what others (physicians) can do than patients: you inspire all of us,” expressed Dolsten.

The Alpha-1 Foundation applauds and supports these types of initiatives, in which patients become partners and are of vital importance for therapeutic development. 

The panel also mentioned that it is critical to spread awareness and education in the medical community, and being able to have early diagnosis and detection, while mentioning the Accelerating Medicines Partnership (AMP), a public-private partnership between the NIH, the U.S. Food and Drug Administration (FDA), multiple biopharmaceutical, and life science companies, as well as non-profit organizations to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets for therapeutics.

The ultimate goal of AMP is to increase the number of new diagnostics and therapies for patients and reduce the time and cost of developing them.

“Patient participation is critical for AMP, especially to remind us what we are doing and why-and-who we are doing it for,” said Collins, who also mentioned the Foundation for the National Institutes of Health (FNIH) as being instrumental in bringing together funds and resources from both the private and public sectors, to work in mutual collaboration in research projects that will ultimately benefit the patient community.

The Alpha-1 Foundation applauds these types of initiatives that support research and bring innovative approaches to the table for the benefit of the patient community, as we are committed to finding a cure for Alpha-1 and improving the lives of Alphas, and those affected by the condition, worldwide.

For more information, please visit the Collaboration Ecosystem website and the AMP website.


Print

Device may be ‘game-changer’ for people with lung disease

Wednesday, January 14, 2015
More than 3 million Americans suffer from advanced emphysema, the nation’s third-leading cause of death after heart disease and cancer. Until recently there was little doctors could do to help them other than perform major surgery to...
Divider

COPD video featuring NFL legend, patients and ATS members to air on CBS

Tuesday, January 13, 2015
This month, CBS affiliate stations in major cities will air “COPD: A Guide for Patients and Families,” a video the American Thoracic Society (ATS) produced in collaboration with Sunovion Pharmaceuticals. The video features people with...
Divider

Success of lung cancer drug Opdivo ends clinical trial two years early

Tuesday, January 13, 2015
A new cancer drug, Opdivo, is working so well that pharmaceutical giant Bristol-Myers Squibb announced Monday it is stopping a trial in lung cancer two years ahead of schedule. The trial compared Opdivo to Docetaxel, a type of chemotherapy used...
Divider

CDC: In bad flu season, people with chronic illness shouldn’t wait to take antivirals

Monday, January 12, 2015
The nation is halfway through a bad flu season, dominated by a viral strain that is not very vulnerable to this year’s vaccine, federal health officials said on Friday. Because the virus, a type known as H3N2, can cause severe illness...
Divider

In ‘party town’ of New Orleans, proposal to ban smoking in public places contentious

Monday, January 12, 2015
The haze that still swirls through many New Orleans bars became the spark igniting a fiery debate before the New Orleans City Council Jan. 7 whether to outlaw smoking in most businesses and public spaces across the city. Musicians,...
Divider

An early Christmas present: President signs newborn screening bill

Friday, January 9, 2015
The rare disease community received an early Christmas present from Washington Dec. 18 when President Obama signed The Newborn Screening Saves Lives Reauthorization Act of 2014 (H.R.1281). The U.S. House of Representatives voted Dec....
Divider

CDC, NCI issue first global report on smokeless tobacco use

Thursday, January 8, 2015
The Centers for Disease Control (CDC) and the National Cancer Institute released the first report on the global use and public health impact of smokeless tobacco at the National Conference on Smoking or Health in Mumbai, India, in...
Divider

CDC: Nearly half of older adults with asthma, COPD still smoke

Thursday, January 8, 2015
The Centers for Disease Control this week reported that close to half of U.S. adults over 40 who live with asthma or chronic obstructive pulmonary disease (COPD) still continue to smoke. The information follows a recent CDC report that found...
Divider

Portland Education Day - February 28

Wednesday, January 7, 2015
Click here to view the agenda and invitation for the Portland Alpha-1 Education Day. To register to attend the Portland Alpha-1 Education Day, contact the Alpha-1 Foundation at 800-521-3025 ext 323. Reservations must be made by February 23, 2015.
Divider

Medicare payment for pulmonary rehab gets a boost in 2015

Monday, January 5, 2015
Effective Jan. 1, 2015, the payment rate for hospital outpatient pulmonary rehabilitation programs for Medicare beneficiaries who meet the guidelines for moderate, severe, and very severe chronic obstructive pulmonary disease (COPD) will be...
Divider

Lung CT scan use is expected to surge

Monday, January 5, 2015
Three years ago, Gordon Green, then 55, rejected his primary-care doctor’s suggestion that he get screened for lung cancer. But Green’s history of smoking a pack of cigarettes a day for 30 years and his doctor’s insistence...
Divider

Frederick de Serres, renowned Alpha-1 researcher, passes at age 85

Thursday, January 1, 2015
Frederick de Serres, PhD, a geneticist and research scientist whose epidemiological studies calculated that Alpha-1 genes are far more common and widespread worldwide than had been previously believed, died Dec. 21 at age 85. De Serres, a former...
Divider
First53545556575859606162Last

Article Search

Enter keywords in text box and click Search button for results.

Archive